135 related articles for article (PubMed ID: 2436778)
1. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
Hollinshead AC
Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
[TBL] [Abstract][Full Text] [Related]
2. Lung tumor-associated antigens: thin layer immunoassay.
Hollinshead AC; Stewart TH; Hamilton RL; DiAngelo CR
Cancer Detect Prev; 1983; 6(1-2):185-91. PubMed ID: 6883379
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated antigens in cervical cancer tissues and in sera from patients with cervical cancer or with head and neck cancer.
Ibrahim AN; Robinson RA; Marr L; Abdelal AT; Nahmias AJ
J Natl Cancer Inst; 1979 Aug; 63(2):319-23. PubMed ID: 88537
[TBL] [Abstract][Full Text] [Related]
4. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
Holán V; Síbl O; Hasek M
Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
[TBL] [Abstract][Full Text] [Related]
7. Immunity to tumor-associated antigens in vasectomized men.
Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
[TBL] [Abstract][Full Text] [Related]
8. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
Ravindranath MH; Morton DL; Irie RF
Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
10. Studies of the nature of herpesvirus-induced tumour-associated antigens induced by herpes simplex virus type 1 and further analysis of their relationship with squamous-cell carcinomas of the head and neck region.
Hollinshead AC; Chretien PB; Tarpley JL
IARC Sci Publ (1971); 1975; (11 Pt 2):307-11. PubMed ID: 191376
[TBL] [Abstract][Full Text] [Related]
11. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic cell-mediated testing for human tumor antigens.
Takasugi M; Ward PH; Mickey MR; Terasaki PI
Natl Cancer Inst Monogr; 1972 Dec; 35():251-7. PubMed ID: 4659048
[No Abstract] [Full Text] [Related]
13. The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas.
Bei R; Masuelli L; Trono P; Orvietani PL; Losito S; Marzocchella L; Vitolo D; Albonici L; Mrozek MA; Di Gennaro E; Lista F; Faggioni G; Ionna F; Binaglia L; Manzari V; Budillon A; Modesti A
Int J Oncol; 2007 Dec; 31(6):1301-8. PubMed ID: 17982655
[TBL] [Abstract][Full Text] [Related]
14. [Serologic analysis of tumor antibodies in the sera of patients with carcinoma of the larynx (author's transl)].
Blume N; Milatovic D
Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):405-6. PubMed ID: 7346674
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
Horoszewicz JS; Kawinski E; Murphy GP
Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer.
Kass ES; Greiner JW; Kantor JA; Tsang KY; Guadagni F; Chen Z; Clark B; De Pascalis R; Schlom J; Van Waes C
Cancer Res; 2002 Sep; 62(17):5049-57. PubMed ID: 12208760
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
Eto M; Kodama S; Uemura N; Suzuki M
Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541
[TBL] [Abstract][Full Text] [Related]
18. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Hanai N; Shitara K; Yoshida H
Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100
[TBL] [Abstract][Full Text] [Related]
19. [The detection of laryngeal carcinoma-associated antigens in tissue and serum using three mixed monoclonal antibodies against laryngeal cancer].
Chen O; Guan G; Jin C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(1):43-6. PubMed ID: 9275404
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
Steller MA; Gurski KJ; Murakami M; Daniel RW; Shah KV; Celis E; Sette A; Trimble EL; Park RC; Marincola FM
Clin Cancer Res; 1998 Sep; 4(9):2103-9. PubMed ID: 9748126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]